Back

Valve-in-valve TAVI regardless of risk profile - Discussion

2 September 2019 (15:31 - 15:40)
Organised by:
Congress Presentation Part of: Controversies in the treatment of aortic valve disease Treatment ESC Premium Access ESC Congress 2019

5 More presentations in this session

Presentation thumbnail
Pure aortic regurgitation remains off-limits for TAVI - PRO
Professor T. Folliguet (Creteil, FR)
Slides Video
Presentation thumbnail
Pure aortic regurgitation remains off-limits for TAVI - CON
Doctor R. Makkar (Los Angeles, US)
Slides Video
Presentation thumbnail
Pure aortic regurgitation remains off-limits for TAVI - Discussion
Video
Presentation thumbnail
Valve-in-valve TAVI regardless of risk profile - PRO
Doctor D. Dvir (Jerusalem, IL)
Slides Video
Presentation thumbnail
Valve-in-valve TAVI regardless of risk profile - CON
Professor G. Gerosa (Padua, IT)
Slides Video

Access the full session

Session thumbnail
Controversies in the treatment of aortic valve disease

The Event

Event poster

ESC Congress 2019

2 September 2019 15:31 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources